Supernus Up 3.7%, Federal Court Says Actavis Is Infringing On Patents
February 08, 2016 at 12:51 PM EST
Supernus Pharmaceuticals Inc (NASDAQ: SUPN), a specialty pharmaceutical company that develops treatments for central nervous system ...
